Effects of Multimodal Therapy Versus Myofascial Release Techniques in Patient With Upper Cross Syndrome

May 17, 2025 updated by: Muhammad Naveed Babur, Superior University
Upper Cross Syndrome (UCS) is a frequent condition which is most commonly encountered in the musculoskeletal disorders showing a characteristics pattern of muscular imbalance and dysfunction in the joints of the neck and shoulder region. Upper Cross Syndrome remains a prevalent and debilitating condition, despite optimal approaches aimed at reducing pain and improving function.

Study Overview

Detailed Description

This study investigates the additional benefits of Multimodal Therapy and Myofascial Release Technique in individuals with Upper Cross Syndrome. Rooted .The researcher employs a randomized controlled trial methodology. Participants are divided into two groups: one receiving Multimodal Therapy, and the other receiving Myofascial Release Techniques. Outcomes are assessed over a 6-week period, focusing on pain levels, Posture and functional disability by goniometer, Numeric pain rating scale (NPRS), Neck disability index (NDI) scores and REEDCO posture assessment scale.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Sahiwal, Punjab, Pakistan
        • Alkhidmat hospital Sahiwal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Diagnosed by physician with sign and symptoms includes muscle in neck, chest and shoulder become overactive or underactive creating the X shape.
  • Office worker.
  • Aged 20 to 40 years.
  • Male and females.

Exclusion Criteria:

  • Recent trauma or surgery to the neck or shoulder region.
  • Cancer or Metastasis in the neck or shoulder region.
  • Infection or Abscess in the neck or shoulder region.
  • Neurological conditions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Myofascial Release Technique
"GROUP A (Multimodal Therapy) Group A was treated with multimodal therapy for 30-45 minutes for 2 sessions per week for 6 weeks. Postural education like correct posture and forward head posture exercises like chin tuck in. Patient was sitting on chair. Therapist was standing on side of patient treated part. Strengthening exercises for the deep cervical flexors, shoulder blade stabilizers, and core muscles with 3 Sets of 3 repetitions with hold for 5 seconds of each exercise. Then breathing exercises for 1 minute. Then grade A (pain free range) cervical spine mobilization 1 Set of 3 repetition. During entire treatment session, the therapist kept close eye on patient's discomfort.
Active Comparator: Multimodal Therapy
Group B (Myofascial Release Technique) Group B was treated with multimodal therapy for 30-45 minutes for 2 sessions per week for 6 weeks. Palpate the muscles and fascia to identify areas of restriction. Apply gentle, sustained pressure to the restricted area using the fingertips or knuckles for Fascial Unwinding. Hold the pressure for 3-5 minutes to allow the fascia to release. Encourage the patient to breathe deeply and slowly to promote relaxation. The stretching of tight muscles 1 set of 3 repetitions. Apply gentle, sustained pressure to release tension of these tight muscles, Suboccipital, Scalene, Pectoralis Major, Trapezius, Levator Scapulae

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NUMERIC PAIN RATING SCALE (NPRS)
Time Frame: 12 Months
The 11-point numeric scale ranges from '0' representing "no pain" to feed '10' representing "pain as bad as you can imagine" or "worst pain imaginable".
12 Months
NECK DIABILITY INDEX (NDI)
Time Frame: 12 Months
The questionnaire has been designed to evaluate how cervical pain affects ability in managing daily routine functions. There are 10 sections includes 10 questions related to pain intensity, personal care, weight lifting, reading, headaches, concentration, work , driving, sleeping and recreations. Scale between 0-5 score. Total score is 50. 22% or more score is considering significant activities of daily living disability.
12 Months
REEDCO POSTURE ASSESSMENT SCALE
Time Frame: 12 Months
Standard tool for objective and quality measurement of postural deviation association with pictures. This includes name, sex, age, center, date and physiotherapist. The total score is out of 100. Normal range between 80-100% of ROM. Mild restriction 60-79% ROM.Moderate restriction 40-59% and Severe restriction: 0-39% ROM. Interpretation of scale is Good -10, Fair -5, Poor - 0 the assessment of muscle.
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2025

Primary Completion (Estimated)

June 20, 2025

Study Completion (Estimated)

February 20, 2026

Study Registration Dates

First Submitted

March 25, 2025

First Submitted That Met QC Criteria

March 25, 2025

First Posted (Actual)

April 1, 2025

Study Record Updates

Last Update Posted (Estimated)

May 20, 2025

Last Update Submitted That Met QC Criteria

May 17, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • MSRSW/Batch-Fall23/785

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Extremity Dysfunction

Clinical Trials on Myofascial Release Technique

Subscribe